Condition: Cervical Cancer · Cervical Cancer Screening · HPV DNA · Sponsor: Kenyatta National Hospital
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
This description comes directly from the study's public registry record.
Agnes K Karume, MBChB, MBA, MPH · +254715181283 · karumeagnes@gmail.com
Millicent Masinde, MBChB, MMed, Fell.Gyn Oncology · +254721243740 · dr.msmillies@gmail.com
Always discuss trial participation with your own doctor first.
| Kenyatta National Hospital | Nairobi, Kenya | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07050745